Back

Only 1 in 5 european HF centres "always" initiate all four GDMT pillars during hospitalisation despite near-universal IV iron and uptitration capacity

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure frontiers: from decongestion to advanced therapeutics Multidisciplinary Interventions ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Lian Rekker

University Medical Center Utrecht, Utrecht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Natriuretic peptide receptor 1 targeting chimeras for cardiovascular selective degradation of extracellular proteins
Doctor K. Zhang (Wuhan, CN)
Abstract Slides Video
Presentation thumbnail
Multicenter machine learning based risk assessment model, integrating omics, clinical and patient centred data to prevent recurrent heart failure events
Professor J. Comin-Colet (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Benefits of sotagliflozin across the full range of baseline blood pressure in the SOLOIST-WHF Trial
Doctor E. Zitelny (New York City, US)
Abstract Slides Video
Presentation thumbnail
Pre-event guideline-directed optimized medical therapy intensity and in-hospital mortality in heart failure–related cardiogenic shock: insights from the ALT-SHOCK registry
Doctor G. Guarnieri (Milan, IT)
Abstract Slides Video
Presentation thumbnail
The ACETAZ-HF trial: intravenous furosemide plus oral acetazolamide for rapid decongestion in acute HFrEF and sustained outpatient benefit
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure frontiers: from decongestion to advanced therapeutics

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction - a survey of the HFA and the CCP of the ESC
13 May 2024
thumbnail
Congress Presentation
Feasebility and limitations of early and accelerated therapy following acute decompensated heart failure
18 May 2025
thumbnail
Congress Presentation
START-HF: a multi-centre evaluation of centralised pharmacist-led remote GDMT optimisation in HFrEF
28 August 2026
thumbnail
Congress Presentation
Electronic guidance to improve adherence to Guidelines directed medical therapy (GDMT) in hospitalized patients with HFrEF, a quality improvement initiative
12 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources